Reconciliations of the non-GAAP financial measures presented in the remarks by Billy Gifford, Altria Group, Inc.'s (Altria) Chief Executive Officer, at Altria's 2021 Annual Meeting of Shareholders.
Altria and Consolidated Subsidiaries, Adjusted EPS Results
($ in millions, except per share data) | ||||||||||
Earnings | Provision | Net Earnings | ||||||||
before | Net | Diluted | ||||||||
Income | for Income | Attributable to | ||||||||
Taxes | Taxes | Earnings | Altria | EPS | ||||||
For the year ended December 31, 2020 | ||||||||||
2020 Reported | $ | 6,890 | $ | 2,436 | $ | 4,454 | $ | 4,467 | $ | 2.40 |
NPM Adjustment Items | 4 | 1 | 3 | 3 | - | |||||
Asset impairment, exit, implementation and | 431 | 89 | 342 | 342 | 0.18 | |||||
acquisition-related costs | ||||||||||
Tobacco and health litigation items | 83 | 21 | 62 | 62 | 0.03 | |||||
JUUL changes in fair value | (100) | - | (100) | (100) | (0.05) | |||||
Impairment of JUUL equity securities | 2,600 | - | 2,600 | 2,600 | 1.40 | |||||
ABI-related special items | 763 | 160 | 603 | 603 | 0.32 | |||||
Cronos-related special items | 51 | (2) | 53 | 53 | 0.03 | |||||
COVID-19 special items | 50 | 13 | 37 | 37 | 0.02 | |||||
Tax items | - | (50) | 50 | 50 | 0.03 | |||||
2020 Adjusted for Special Items | $ | 10,772 | $ | 2,668 | $ | 8,104 | $ | 8,117 | $ | 4.36 |
For the year ended December 31, 2019 | ||||||||||
2019 Reported | $ | 766 | $ | 2,064 | $ | (1,298) | $ | (1,293) | $ | (0.70) |
Asset impairment, exit, implementation and | 331 | 62 | 269 | 269 | 0.15 | |||||
acquisition-related costs | ||||||||||
Tobacco and health litigation items | 77 | 19 | 58 | 58 | 0.03 | |||||
Impairment of JUUL equity securities | 8,600 | - | 8,600 | 8,600 | 4.60 | |||||
ABI-related special items | (383) | (80) | (303) | (303) | (0.16) | |||||
Cronos-related special items | 928 | 288 | 640 | 640 | 0.34 | |||||
Tax items | - | 99 | (99) | (99) | (0.05) | |||||
2019 Adjusted for Special Items | $ | 10,319 | $ | 2,452 | $ | 7,867 | $ | 7,872 | $ | 4.21 |
2020 Net Earnings Adjusted for Special Items | $ | 8,117 | $ | 4.36 | ||||||
2019 Net Earnings Adjusted for Special Items | $ | 7,872 | $ | 4.21 | ||||||
% Change | 3.1 % | 3.6 % |
1
Altria and Consolidated Subsidiaries, Adjusted EPS Results
($ in millions, except per share data) | ||||||||||
Earnings | Provision | Net Earnings | ||||||||
before | Net | Diluted | ||||||||
Income | for Income | Attributable to | ||||||||
Taxes | Taxes | Earnings | Altria | EPS | ||||||
For the quarter ended March 31, 2021 | ||||||||||
2021 Reported | $ | 1,937 | $ | 516 | $ | 1,421 | $ | 1,424 | $ | 0.77 |
NPM Adjustment Items | (32) | (8) | (24) | (24) | (0.01) | |||||
Implementation and acquisition-related costs | 48 | 11 | 37 | 37 | 0.02 | |||||
Tobacco and health litigation items | 35 | 9 | 26 | 26 | 0.01 | |||||
JUUL changes in fair value | 200 | - | 200 | 200 | 0.10 | |||||
ABI-related special items | (128) | (28) | (100) | (100) | (0.05) | |||||
Cronos-related special items | (70) | - | (70) | (70) | (0.04) | |||||
Loss on early extinguishment of debt | 649 | 153 | 496 | 496 | 0.27 | |||||
Tax items | - | 6 | (6) | (6) | - | |||||
2021 Adjusted for Special Items | $ | 2,639 | $ | 659 | $ | 1,980 | $ | 1,983 | $ | 1.07 |
For the quarter ended March 31, 2020 | ||||||||||
2020 Reported | $ | 2,108 | $ | 558 | $ | 1,550 | $ | 1,552 | $ | 0.83 |
Implementation and acquisition-related costs | 395 | 95 | 300 | 300 | 0.16 | |||||
Tobacco and health litigation items | 24 | 5 | 19 | 19 | 0.01 | |||||
ABI-related special items | 56 | 12 | 44 | 44 | 0.03 | |||||
Cronos-related special items | 89 | (6) | 95 | 95 | 0.05 | |||||
Tax items | - | (24) | 24 | 24 | 0.01 | |||||
2020 Adjusted for Special Items | $ | 2,672 | $ | 640 | $ | 2,032 | $ | 2,034 | 1.09 | |
Adjusted diluted EPS Change Q1 2021 vs. Q1 2020 | (1.8)% |
2
Altria and Consolidated Subsidiaries, Selected Financial Data for Smokeable Products
($ in millions) | |||||
Full Year Ended December 31, | |||||
2020 | 2019 | Change | |||
Net Revenues | $ | 23,089 | $ | 21,996 | |
Excise taxes | (5,162) | (5,166) | |||
Revenues net of excise taxes | $ | 17,927 | $ | 16,830 | |
Reported OCI (1) | $ | 9,985 | $ | 9,009 | |
NPM Adjustment Items | 4 | - | |||
Asset impairment, exit and implementation costs | 2 | 92 | |||
Tobacco and health litigation items | 79 | 72 | |||
COVID-19 special items | 41 | $ | - | ||
Adjusted OCI | $ | 10,111 | $ | 9,173 | 10.2 % |
- Operating companies income (OCI) is defined as operating income before general corporate expenses and amortization of intangibles.
3
Attachments
- Original document
- Permalink
Disclaimer
Altria Group Inc. published this content on 20 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2021 14:07:00 UTC.